KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 7,620.00
-50.00 (-0.65%)
At close: Sep 11, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 83.11 billion as of September 11, 2026. Its market cap has decreased by -46.34% in one year.
Market Cap
83.11B
Enterprise Value
88.66B
Revenue
93.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,620.00
ChartMarket Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 83.11B, a decrease of -54.78%. That is a compound annual growth rate of -12.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 83.11B | -41.38% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 101.11B |
| DongKoo Bio & Pharma | 94.78B |
| H.PIO | 84.88B |
| Sam-A Pharm. | 84.84B |
| Samik Pharmaceutical Company LTD. | 83.56B |
| Daehan Nupharm | 78.74B |
| Polaris AI Pharma | 72.79B |
| GL Pharm Tech | 72.66B |